NIAID Site Search

In July, NIAID hosted a workshop of technology developers, immunologists, maternal health researchers and clinicians to explore the importance and challenges of measuring, predicting and improving reproductive health in the context of maternal and fetal immune systems.

Published: October 25, 2023

Sample application from Emily Troemel, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: October 11, 2024

Sample application from Mengxi Jiang, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: November 29, 2022

Mosquitoes are considered one of the most dangerous animals on earth because of their broad distribution and the many pathogens they transmit to humans. Dr. Patricia Scaraffia, Associate Professor at the Tulane University School of Public Health and Tropical Medicine, has dedicated her career to understanding the metabolism of the mosquito species that carries the pathogens responsible for dengue, Zika, chikungunya, and yellow fever to humans. NIAID reached out to Dr. Scaraffia about her team’s research.

Published: August 20, 2024

Last Reviewed: August 6, 2024

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: August 6, 2024

Sample application from Yingru Liu, Ph.D., for Small Business Innovation Research (SBIR) Phase II grant (R44).

Last Reviewed: November 25, 2022

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in 2006.

Last Reviewed: August 6, 2019

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in August 2003.

Last Reviewed: August 6, 2019

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024